NMRA

Neumora Therapeutics, Inc. NMRA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$129.21M total
Siren, L.L.C.
$14.45M0.0%
BlackRock, Inc.
$13.25M+279.3%
SOFTBANK GROUP CORP.
$10.35M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$7.94M+20.0%
MIC Capital Management UK LLP
$7.58M0.0%
FMR LLC
$5.95M0.0%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST
$5.63M0.0%
GEODE CAPITAL MANAGEMENT, LLC
$4.43M+139.9%
ICONIQ Capital, LLC
$4.35M0.0%
TWO SIGMA INVESTMENTS, LP
$3.82M+10.2%
ORBIMED ADVISORS LLC
$3.64MNew
Lunate Capital Ltd
$3.61M0.0%
Boxer Capital Management, LLC
$3.40MNew
JOHNSON & JOHNSON
$3.14M0.0%
STATE STREET CORP
$2.69M+296.8%
TUDOR INVESTMENT CORP ET AL
$2.31M+75.8%
Ikarian Capital, LLC
$2.17M0.0%
RENAISSANCE TECHNOLOGIES LLC
$2.15M-9.1%
Affinity Asset Advisors, LLC
$1.82MNew
MARSHALL WACE, LLP
$1.54M-24.3%
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.52M+384.1%
CITADEL ADVISORS LLC
$1.41M+141.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$1.40M+59.6%
NORTHERN TRUST CORP
$1.36M+306.6%
Ensign Peak Advisors, Inc
$1.33MNew
See all 113 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NMRA

Earnings Per Share

13fpro.ai/company/NMRA

Loading ratio trend…

NMRA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Neumora Therapeutics, Inc. (NMRA): stock profile, AI score and financials

Neumora Therapeutics, Inc. (NMRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NMRA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of NMRA by reported 13-F value include Siren, L.L.C., BlackRock, SOFTBANK GROUP, based on the most recent SEC filings. NMRA trades on the Nasdaq exchange and files with the SEC under CIK 1885522. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NMRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Neumora Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1885522 →